Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

From Diabetes to Dementia: Identifying Key Genes in the Progression of Cognitive Impairment

18 Oct 2024

Abstract excerpt

OBJECTIVES: To provide a basis for further research on the molecular mechanisms underlying type 2 diabetes-associated mild cognitive impairment (DCI) using two bioinformatics methods to screen key genes involved in the progression of mild cognitive impairment (MCI) and type 2 diabetes. METHODS: RNA sequencing data of MCI and normal cognition groups, as well as expression profile and sample information data of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Neurological Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39452046
DOI: 10.3390/brainsci14101035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

From Diabetes to Dementia: Identifying Key Genes in the Progression of Cognitive ImpairmentPMID 39452046Read ↗

Bioinformatics Analysis of Next Generation Sequencing Data Identifies Molecular Biomarkers Associated With Type 2 Diabetes MellitusSemantic proximity Read ↗

The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD)Semantic proximity Read ↗

Exploring the Key Genes and Identification of Potential Diagnosis Biomarkers in Alzheimer’s Disease Using Bioinformatics AnalysisSemantic proximity Read ↗

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s diseaseSemantic proximity Read ↗

Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic StrategiesSemantic proximity Read ↗

Identification of Key Pathways and Genes in Dementia via Integrated Bioinformatics AnalysisSemantic proximity Read ↗

Integrated Analysis of Weighted Gene Coexpression Network Analysis Identifying Six Genes as Novel Biomarkers for Alzheimer’s DiseaseSemantic proximity Read ↗

miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer’s diseaseSemantic proximity Read ↗

Identification of candidate biomarkers and signaling pathways associated with Alzheimer’s disease using bioinformatics analysis of next generation sequencing dataSemantic proximity Read ↗

Identification of diagnostic genes for both Alzheimer’s disease and Metabolic syndrome by the machine learning algorithmSemantic proximity Read ↗

Analysis of key genes and pathways associated with the pathogenesis of Type 2 diabetes mellitusSemantic proximity Read ↗

Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.